Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This multicenter study will be divided into 2 phases. The first phase will be an open label,
dose-escalation phase, while the second will be a blinded, randomized, vehicle-controlled,
parallel-group, dose-response phase. The second phase will only start if the first phase
succeeds in establishing well tolerated dose(s). Patients with moderate to severe acne
vulgaris in the face will be included.The results from part 2 has been presented in the
result section.